isradipine has been researched along with Proteinuria in 4 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isradipine lowered the maternal mean arterial blood pressure effectively in women with nonproteinuric hypertension but did not do so in women with proteinuria at recruitment or appearing during treatment." | 9.08 | Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. ( Andersson, KE; Forman, A; Ingemarsson, I; Lindberg, B; Lindeberg, S; Lunell, NO; Marsàl, K; Skajaa, K; Wide-Swensson, DH, 1995) |
| "Isradipine lowered the maternal mean arterial blood pressure effectively in women with nonproteinuric hypertension but did not do so in women with proteinuria at recruitment or appearing during treatment." | 5.08 | Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. ( Andersson, KE; Forman, A; Ingemarsson, I; Lindberg, B; Lindeberg, S; Lunell, NO; Marsàl, K; Skajaa, K; Wide-Swensson, DH, 1995) |
| " In the long-term study presented here, the effects of isradipine, a dihydropyridine calcium antagonist, on the course of the nephropathy were investigated and compared with the effects of captopril in 31 African Americans with NIDDM and proteinuria (> or = 500 mg/day)." | 5.08 | Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy. ( Campbell, O; Guasch, A; Macon, E; Nzerue, C; Parham, M; Zayas, CF, 1997) |
| "In a double-blind, randomized trial with 26 male white patients with essential hypertension in World Health Organization Stages I and II, we examined the impact of calcium entry blockade (5 to 10 mg/day isradipine, N = 14) and beta-blockade (100 to 200 mg/day metoprolol, N = 12) on early markers of hypertensive nephropathy before and after 7 weeks' treatment." | 5.07 | Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hypertensive nephropathy. ( Rockstroh, J; Rüddel, H; Schächinger, H; Schlebusch, H; Schmieder, RE; Schulte, W, 1992) |
| "Fifty patients with stable slight and moderate uncomplicated essential hypertension, treated by ramipril, atenolol, or isradipine, were examined." | 3.70 | [Protein markers in evaluation of nephroprotective effects of antihypertensive drugs in patients with arterial hypertension]. ( Betekhtina, VA; Rakov, SS, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wide-Swensson, DH | 1 |
| Ingemarsson, I | 1 |
| Lunell, NO | 1 |
| Forman, A | 1 |
| Skajaa, K | 1 |
| Lindberg, B | 1 |
| Lindeberg, S | 1 |
| Marsàl, K | 1 |
| Andersson, KE | 1 |
| Guasch, A | 1 |
| Parham, M | 1 |
| Zayas, CF | 1 |
| Campbell, O | 1 |
| Nzerue, C | 1 |
| Macon, E | 1 |
| Rakov, SS | 1 |
| Betekhtina, VA | 1 |
| Schmieder, RE | 1 |
| Rüddel, H | 1 |
| Schlebusch, H | 1 |
| Rockstroh, J | 1 |
| Schächinger, H | 1 |
| Schulte, W | 1 |
3 trials available for isradipine and Proteinuria
| Article | Year |
|---|---|
Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Hear | 1995 |
Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Black People; Calcium Channel Blockers; Capto | 1997 |
Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hypertensive nephropathy.
Topics: Antihypertensive Agents; Dihydropyridines; Double-Blind Method; Humans; Hypertension; Isradipine; Ki | 1992 |
1 other study available for isradipine and Proteinuria
| Article | Year |
|---|---|
[Protein markers in evaluation of nephroprotective effects of antihypertensive drugs in patients with arterial hypertension].
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Apolipoproteins; Atenolol; Biomarkers; Complement | 2000 |